Characterization and management of mobocertinib (TAK-788) induced skin toxicity in patients with EGFR exon 20 insertion+ (ex20ins+) non-small cell lung cancer (NSCLC) who previously received platinum chemotherapy Meeting Abstract
| Authors: | Yang, J. C. H.; Ramalingam, S. S.; Kim, T. M.; Kim, S. W.; Riely, G. J.; Mekhail, T.; Nguyen, D.; Garcia Campelo, M. R.; Felip, E.; Bazhenova, L.; Jin, S.; Griffin, C.; Bunn, V.; Lin, J.; Churchill, E. N.; Mehta, M.; Janne, P. A.; Zhou, C. |
| Abstract Title: | Characterization and management of mobocertinib (TAK-788) induced skin toxicity in patients with EGFR exon 20 insertion+ (ex20ins+) non-small cell lung cancer (NSCLC) who previously received platinum chemotherapy |
| Meeting Title: | ESMO Congress 2021 |
| Journal Title: | Annals of Oncology |
| Volume: | 32 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2021 Sep 16-21 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-09-01 |
| Start Page: | S975 |
| Language: | English |
| ACCESSION: | WOS:000700527702249 |
| DOI: | 10.1016/j.annonc.2021.08.1836 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract #1231P -- Source: Wos |
